Riise J, Meyer S, Blaas I, Chopra A, et al. Rituximab-treated lymphoma patients develop strong CD8 T-cell responses following COVID-19 vaccination. Br J Haematol 2022 Mar 7. doi: 10.1111/bjh.18149.
PMID: 35254660